NCT00482937View on ClinicalTrials.gov

Safety and Pharmacodynamic Study of CD-NP

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

January 31, 2007

Study Completion Date

May 31, 2007

Conditions

Heart Failure, Congestive

Interventions

DRUG

CD-NP

Trial Locations (1)

55404

DaVita Clinical Research, Minneapolis

Sponsors

Lead Sponsor

Nile Therapeutics

All Listed Sponsors

lead

Nile Therapeutics

INDUSTRY

NCT00482937 - Safety and Pharmacodynamic Study of CD-NP | Biotech Hunter | Biotech Hunter